PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Arix Bioscience Plc | LSE:ARIX | London | Ordinary Share | GB00BD045071 | ORD 0.001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 95.50 | 93.00 | 98.00 | 96.00 | 95.50 | 96.00 | 137,536 | 08:28:39 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.5 | -75.6 | -53.8 | - | 129 |
Arix Bioscience (ARIX) News Headlines
Arix Bioscience News
| Date | Time | Source | Headline |
|---|---|---|---|
| 29/5/2020 | 13:40 | ALNCF |  Alliance News Flash Headline |
| 29/5/2020 | 13:38 | PRNUS | Arix Bioscience Plc - Harpoon presents interim Phase 1 data for HPN424 |
| 29/5/2020 | 13:06 | UKREG | Arix Bioscience plc Autolus presents additional AUTO3 data in DLBCL |
| 27/5/2020 | 16:40 | UKREG | Arix Bioscience Plc Second Price Monitoring Extn |
| 27/5/2020 | 16:35 | UKREG | Arix Bioscience Plc Price Monitoring Extension |
| 20/5/2020 | 07:00 | PRNUS | Arix Bioscience Plc - Amplyx closes $53 million Series C extension |
| 12/5/2020 | 07:00 | PRNUS | Arix Bioscience Plc - Notice of Annual General Meeting |
| 28/4/2020 | 09:23 | PRNUS | Arix Bioscience Plc - Pharmaxis announces new data in myelofibrosis |
| 27/4/2020 | 16:59 | ALNC | Arix Bioscience Notes First Patient Dosed In Harpoon's HPN217 Trial |
| 27/4/2020 | 13:12 | UKREG | Arix Bioscience plc Harpoon doses first patient in multiple myeloma trial |
1 Year Arix Bioscience Chart |
Intraday Arix Bioscience Chart |
